Dr Samantha Thomas, at the event on 8 November entitled “Targeted Delivery of Therapeutic Payloads Using Stem Cell derived Exosome”, presented in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the significant advantages of ReNeuron’s CustomEX™ drug delivery platform.
The presentation can be viewed by clicking here.
Randolph Corteling, our Chief Scientific Officer, presented at the event on Tuesday 14 March. His presentation entitled – ‘CustomEXTM a new stem cell-derived drug delivery platform’, highlighted the advantages of ReNeuron’s customisable stem-cell derived exosome drug delivery platform (CustomEXTM) over current technologies.
The presentation can be viewed by clicking here.
ReNeuron presented new data highlighting the advantages of its novel type of iPSCs including data
from the Company’s collaboration with University College London.
The presentation entitled Conditionally Immortalised iPSCs: A New Approach to Off-the-Shelf Allogeneic iPSC-Derived Cell Therapies can be viewed by clicking here.
The ReNeuron presentation from the Extracellular Vesicle-Based Therapeutic Development Summit (October 2022) is now available to view.
Dr Randolph Corteling presented new data at the Extracellular Vesicle-Based Therapeutic Development Summit in Boston, MA, highlighting the significant advantages of the Company’s stem cell derived exosome approach.
To view the presentation of the preliminary results for the year ended 31 March 2022 please click here.
A recording of the webcast can be accessed via the following link:
The ReNeuron presentations from the International Society of Cell and Gene Therapy Annual Meeting (ISCT 2022) are now available to view.
Dr Randolph Corteling, Vice President of Research at ReNeuron presented as an exosomes global subject matter expert in two separate sessions:
– SCIENCE & INNOVATION – State of the Art in EV (Exosome) Research: Rigor and Function – to view click here.
– ISCT Scientific Signature Series – Therapeutic Advances with native and engineered human EVs – to view click here.
CFO, Catherine Isted also presented a short corporate presentation as part of the event – to view click here.
February 2022: To view the latest investor presentation click here…
30 November 2021: To view the presentation of the 2021 interim results and business update please click here.
Web Cast Recording – To log on to view a recording of the analyst presentation webcast please click here…
To view the presentation of the preliminary results for the year ended 31 March 2021 please click here.
A recording of the webcast can be accessed via the following link:
Olav Hellebo, CEO, presented at the Foundation Fighting Blindness Investing in Cures Summit (April 12 – 17, 2021).
A recording of the session can be found here:
The slides presented are available by clicking here..
